Patents by Inventor Shio Kumar Singh

Shio Kumar Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160009752
    Abstract: The present invention relates to the synthesis of pregnane-oximino-aminoalkyl-ethers and their antidiabetic and antidyslipidemic activities. More particularly, the invention relates to the synthesis of compounds of formula 3 and biological profile thereof. Further the invention relates to compounds of formula 3 and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: January 24, 2014
    Publication date: January 14, 2016
    Inventors: Prem Chandra VERMA, Jyoti GUPTA, Dharmendra Pratap SINGH, Varsha GUPTA, Hari Narayan KUSHWAHA, Anamika MISRA, Neha RAHUJA, Rohit SRIVASTAVA, Natasha JAISWAL, Ashok Kumar KHANNA, Akhilesh Kumar TAMRAKAR, Shio Kumar SINGH, Anil Kumar DWIVEDI, Arvind Kumar SRIVASTAVA, Ram PRATAP
  • Publication number: 20110077294
    Abstract: The present invention provides an optically active compound of general formula (I) and salts thereof: wherein R? is selected from a group consisting of t-butyl amine, n-butylamine, iso-butylamine, iso-propyl amine, 4-phenyl-piperazine-1-ylamine, 4-(2-methoxyphenyl)-piperazin-1-ylamine, and 3,4-dimethoxy phenethyl amine; wherein R1, R2 and R3 are selected from the group consisting of hydrogen, methyl or iso pentenyl; R4, R5 and R6 are selected from the group consisting of Oil, O-alkyl, O-benzyl, O-substituted phenyl or combination thereof.
    Type: Application
    Filed: August 2, 2007
    Publication date: March 31, 2011
    Inventors: Ram Pratap, Himanshu Singh, Alok Kumar Verma, Amar Bahadur Singh, Priti Priti Tiwari Tiwari, Mukesh Srivastava, Arvind Kumar Srivastava, Anil Kumar Dwivedi, Satyawan Singh, Pratima Pnahma Svivastva Srivastava, Shio Kumar Singh, Chandishwar Nath, Ram Raghubir
  • Patent number: 7404962
    Abstract: A combination kit for the treatment of malaria caused by Plasmodium vivax (P. vivax) having individual doses of an anti-malarial agent, 3-[1-[[4-[(6-methoxy-8-quinolinyl)amino]pentyl]amino]ethylidene]-dihydro-2(3H)-furanone (I) in the form of capsules; individual doses of the anti-malarial agent, chloroquine in the form of tablets; and instruction material for the administration of the two anti-malarial drugs. The combination kit is particularly suited for a 6 days treatment regimen where the treatment is rendered by five tablets containing 500 mg of chloroquine phosphate (equivalent to 300 mg base), three to be taken on day one and one each on days two and three; and five capsules containing 25 mg of 3-[1-[[4-[(6-methoxy-8-quinolinyl)amino]pentyl]amino]ethylidene]-dihydro-2(3H)-furanone (I), one each to be taken on days two to six.
    Type: Grant
    Filed: August 30, 2000
    Date of Patent: July 29, 2008
    Assignees: Nicholas Piramal India Limited, Council of Scientific and Industrial Research
    Inventors: Francis Joseph Pinto, Swati Ajay Piramal, Ram Pratap, Amiya Prasad Bhaduri, Harsh Pati Thapliyal, Sunil Kumar Puri, Guru Prasad Dutta, Anil Kumar Dwivedi, Satyawan Singh, Pratima Srivastava, Vikash Chandra Pandey, Sudhir Srivastava, Shio Kumar Singh, Ram Chandra Gupta, Jagdishwar Sahai Srivastava, Omkar Prasad Asthana
  • Patent number: 7183291
    Abstract: The present invention a novel use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4-(6-methoxy-8-quinolinyl)-1,4-pentanediamine in the treatment and controlling the spread of malaria. In particular, the present invention discloses a method of treatment of malaria by the use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4-(6-methoxy-8-quinolinyl)-1,4-pentanediamine as a gametocytocidal agent.
    Type: Grant
    Filed: May 21, 1999
    Date of Patent: February 27, 2007
    Assignee: Council of Scientific and Industrial Research
    Inventors: Ram Pratap, Amiya Prasad Bhaduri, Harsh Pati Thapliyal, Sunil Kumar Puri, Guru Prasad Dutta, Anil Kumar Dwivedi, Satyawan Singh, Pratima Srivastava, Vikash Chandra Pandey, Sudhir Srivastava, Shio Kumar Singh, Ram Chandra Gupta, Jagdishwar Sahai Srivastava, Omkar Prasad Asthana
  • Publication number: 20030199697
    Abstract: The present invention a novel use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4-(6-methoxy-8-quinolinyl)-1,4-pentanediamine in the treatment and contolling the spread of malaria. In particular, the present invention discloses a method of treatment of malaria by the use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4-(6-methoxy-8-quinolinyl)-1,4-pentanediamine as a gametocytocidal agent.
    Type: Application
    Filed: May 21, 1999
    Publication date: October 23, 2003
    Inventors: RAM PRATAP, AMIYA PRASAD BHADURI, HARSH PATI THAPLIYAL, SUNIL KUMAR PURI, GURU PRASAD DUTTA, ANIL KUMAR DWIVEDI, SATYAWAN SINGH, PRATIMA SRIVASTAVA, VIKASH CHANDRA PANDEY, SUDHIR SRIVASTAVA, SHIO KUMAR SINGH, RAM CHANDRA GUPTA, JAGDISHWAR SAHAI SRIVASTAVA, OMKAR PRASAD ASTHANA